ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Calamos Wealth Management LLC's Holding History (CIK: 0001455258)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 66,000 Value ($000) $97 Avg Close — Range —
Q3 2025
Shares 66,000 Value ($000) $109 Avg Close — Range —
Q2 2025
Shares 65,000 Value ($000) $85 Avg Close — Range —
Q1 2025
Shares 80,000 Value ($000) $92 Avg Close — Range —
Q4 2024
Shares 81,000 Value ($000) $86 Avg Close — Range —
Q3 2024
Shares 98,000 Value ($000) $115 Avg Close — Range —
Q2 2024
Shares 98,000 Value ($000) $106 Avg Close — Range —
Q1 2024
Shares 93,000 Value ($000) $87 Avg Close — Range —
Q4 2023
Shares 368,000 Value ($000) $365 Avg Close — Range —
Q3 2023
Shares 379,000 Value ($000) $352 Avg Close — Range —